Supreme Court Confirms Full Scope Enablement Standard in Amgen v. Sanofi
May 31, 2023
By: Thomas Hedemann and Patrick Doyle
Reuters Westlaw Today
Axinn counsel Thomas Hedemann and associate Patrick Doyle co-authored the Reuters Westlaw Today article, "Supreme Court Confirms Full Scope Enablement Standard in Amgen v. Sanofi."
Click here to access the article. Republished with the permission of Thomson Reuters.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ITCTLA Mock Hearing Program 2025
Speaking Engagement
Intellectual Property
IBA Annual Conference 2025
Speaking Engagement
Antitrust
GCR Live: Global Merger Control 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
Shifting Trends in Healthcare Antitrust Enforcement: Navigating the Evolving Landscape
Axinn Viewpoints
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
In Fashion, One Day You’re In and the Next Day You’re Out (Of Chances to Plead Violations of the Sherman Act)
Axinn Viewpoints
Antitrust